SHP Share PerformanceMore
|52 week high||5,067.0 03/03/17|
|52 week low||3,435.5 27/10/17|
|52 week change||-740.5 (-16.44%)|
|4 week volume||52,487,403 19/11/17|
Latest News« previous» nextMore
Shire plc : New Formulation of ONCASPAR® (pegaspargase) Receives Marketing Authorization in Europe for Patients with Acute Lymphoblastic Leukemia (ALL)
13/12/2017 - 07:25 RNS
08/12/2017 - 16:00 RNS
Shire plc: Directorate change Chief Financial Officer update December 8, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotech leader in rare diseases, announced on August 21, 2017, that Jeff Poulton, Chief Financial Officer, would leave Shire at the end of the year. On November 20, 2017, Shire announced that Thomas Dittrich will join the company as Chie...
05/12/2017 - 14:15 StockMarketWire
Shire and Rani Therapeutics have confirmed that they have entered into a collaboration agreement to evaluate the use of t...
Shire and Rani Therapeutics Enter into Collaboration to Evaluate Use of the Rani Pill(TM) Technology for the Oral Delivery of Factor Therapy
05/12/2017 - 12:00 RNS
01/12/2017 - 12:30 RNS
Shire plc: Total voting rights Total Voting Rights December 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies the market of the following: As at November 30, 2017, the Company's issued ordinary share capital comprised 909...
01/12/2017 - 08:34 StockMarketWire
Shire has appointed Andreas Busch as executive vice president, head of research and development and chief scientific offic...
01/12/2017 - 08:00 RNS
Shire Appoints Andreas Busch, Ph D as Head of Research and Development and Chief Scientific Officer Shire Appoints Andreas Busch, Ph D as Head of Research and Development and Chief Scientific Officer Howard Mayer, MD to become Chief Medical Officer Cambridge, MA - December 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotech leader in...
Latest discussion posts More
“"When the market starts to focus on that and not the debt you wont see this for dust." I'd like to see some dust as this is my second biggest holding. Games”▼
“Hope you're right about not seeing it for dust, SM, just bought a shedload”▼
“It could have something to do with the fact that this is heavily oversold. This is a growth story with a credible pipeline. It's also generating plenty of cash. When the ...”▼
Codes & Symbols
|Symbols||SHP, LSE:SHP, SHP.L, SHP:LN, LON:SHP, XLON:SHP|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment